Early work demonstrated that some two-dimensional (2D) materials could kill bacteria by using their sharp edges to physically rupture the bacteria envelope, which presents distinct advantages over traditional antibiotics, as bacteria are not able to evolve resistance to the former. This mechano-bactericidal mode of action, however, suffers from low antibacterial efficiency, fundamentally because of random orientation of 2D materials outside the bacteria, where the desirable "edge-to-envelope" contacts occur with low probability. Here, we demonstrate a proof-of-concept approach to significantly enhance the potency of the mechano-bactericidal activity of 2D materials. This approach is in marked contrast with previous work, as the 2D materials are designed to be generated inside the bacteria from a molecularly engineered monomer in a self-assembled manner, profoundly promoting the probability of the "edge-to-envelope" contacts. The rationale in this study sheds light on a mechanically new nanostructure-enabled antibacterial strategy to combat antibiotic resistance.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.nanolett.4c00803 | DOI Listing |
Infect Chemother
December 2024
Vaccine Bio Research Institute, College of Medicine, The Catholic University of Korea Seoul, Korea.
Background: Healthcare-associated infections (HAI) caused by multidrug-resistant organisms have emerged as a significant global issue, posing substantial challenges to healthcare systems. Low- and intermediate-level disinfectants are extensively utilized for cleaning and disinfecting surfaces in hospitals to mitigate environmental transmission of HAI. Therefore, the need for more effective and environmentally safe disinfectants is increasing.
View Article and Find Full Text PDFHeliyon
January 2025
D. Serikbayev East Kazakhstan Technical University, Oskemen, 070000, Kazakhstan.
This study evaluates the antibacterial properties and physicochemical characteristics of -tantalum-copper (Ta-Cu) coatings deposited on titanium alloy substrates using high-power magnetron sputtering. Implant-associated infections, particularly those caused by bacterial adhesion and biofilm formation, pose significant challenges in the field of orthopedic and dental implants. To address these issues, Ta-Cu coatings with varying copper content (∼3.
View Article and Find Full Text PDFSmall
January 2025
College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310058, China.
Lubricant-mediated surfaces limit their practical application in transparent antifouling due to the inherent drawbacks of lubricant loss and poor transparency. Liquid-Like Surfaces(LLSs)are expected to solve these problems. Herein, inspired by the skin structure of globefish, some slippery LLSs are prepared with the cyclodextrin-eugenol inclusion complexes as the poison glands and flexible silicone chains as the liquid-like layer.
View Article and Find Full Text PDFBiomaterials
December 2024
Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, Jiangsu, 215123, China. Electronic address:
In recent years, there has been growing interest in understanding the role of bacteria within tumors and their potential as targets for cancer therapy. In this work, we developed an ellagic acid (EA) - endogenous protein (eP) nanocomposite (eP-EA) to target tumors by EPR (enhanced permeability and retention), kill bacteria within tumors to regulate anti-tumor immune responses. The potential mechanism of eP-EA treatment is associated with the reduced abundance and diversity of microorganisms within the tumor, culminating with an altered metabolism within the Tumor microenvironment (TME).
View Article and Find Full Text PDFCell Discov
January 2025
School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
We investigated a novel cancer immunotherapy strategy that effectively suppresses tumor growth in multiple solid tumor models and significantly extends the lifespan of tumor-bearing mice by introducing pathogen antigens into tumors via mRNA-lipid nanoparticles. The pre-existing immunity against the pathogen antigen can significantly enhance the efficacy of this approach. In mice previously immunized with BNT162b2, an mRNA-based COVID-19 vaccine encoding the spike protein of the SARS-CoV-2 virus, intratumoral injections of the same vaccine efficiently tagged the tumor cells with mRNA-expressed spike protein.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!